$36M sweet spot round size
Most of their 1 investments are in rounds between $36M and $36M
2010
EPIRUS Biopharmaceuticals raised $36M on April 16, 2014
Investors: Mousse Partners, 5AM Ventures, Montreux Equity Partners, Gibralt Capital Corporation, Adage Capital Management and Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. raised undisclosed on June 27, 2018
Investors: Livzon